HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism.

Alamri MA, Afzal M, Pandey SN, Afzal O, Akela MA, Rekha A

Open source

DOI
10.17179/excli2026-9414
Published
2026
Container
EXCLI journal
Publisher
IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund
Open access
yes

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17179/excli2026-9414,
  title = {HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism.},
  author = {Alamri MA and Afzal M and Pandey SN and Afzal O and Akela MA and Rekha A},
  year = {2026},
  journal = {EXCLI journal},
  doi = {10.17179/excli2026-9414},
  url = {https://doi.org/10.17179/excli2026-9414}
}

RIS

TY  - JOUR
TI  - HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism.
AU  - Alamri MA
AU  - Afzal M
AU  - Pandey SN
AU  - Afzal O
AU  - Akela MA
AU  - Rekha A
PY  - 2026
JO  - EXCLI journal
DO  - 10.17179/excli2026-9414
UR  - https://doi.org/10.17179/excli2026-9414
ER  - 

APA

MA, A., M, A., SN, P., O, A., MA, A., & A, R. (2026). HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism.. EXCLI journal. https://doi.org/10.17179/excli2026-9414

Source records